| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.3% | 78.0% | ▲ +1.6% |
| Healthcare Services | 24.2% | 21.0% | ▼ -3.1% |
| Healthcare Equipment & Supplies | 0.9% | 0.9% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.0% | 77.2% | ▼ -0.7% |
| Healthcare Services | 21.0% | 21.8% | ▲ +0.8% |
| Healthcare Equipment & Supplies | 0.9% | 1.0% | ▲ +0.2% |
Comparing Mar 2026 → Apr 2026
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Fortis Healthcare Limited ₹13.92 Cr |
Healthcare Services | 7.88% | 8.50% | +0.62% |
| 2 | Cohance Lifesciences Limited ₹2.28 Cr |
Pharmaceuticals & Biotechnology | 0.93% | 1.39% | +0.46% |
| 3 | Neuland Laboratories Limited ₹3.74 Cr |
Pharmaceuticals & Biotechnology | 1.97% | 2.29% | +0.32% |
| 4 | Glenmark Pharmaceuticals Limited ₹10.49 Cr |
Pharmaceuticals & Biotechnology | 6.10% | 6.40% | +0.30% |
| 5 | Laurus Labs Limited ₹12.40 Cr |
Pharmaceuticals & Biotechnology | 7.34% | 7.57% | +0.23% |
| 6 | Wockhardt Limited ₹3.34 Cr |
Pharmaceuticals & Biotechnology | 1.85% | 2.04% | +0.19% |
| 7 | Mankind Pharma Limited ₹7.36 Cr |
Pharmaceuticals & Biotechnology | 4.32% | 4.49% | +0.17% |
| 8 | Piramal Pharma Limited ₹2.90 Cr |
Pharmaceuticals & Biotechnology | 1.61% | 1.77% | +0.16% |
| 9 | Syngene International Limited ₹2.57 Cr |
Healthcare Services | 1.41% | 1.57% | +0.16% |
| 10 | Poly Medicure Limited ₹1.67 Cr |
Healthcare Equipment & Supplies | 0.86% | 1.02% | +0.16% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Lupin Limited ₹16.18 Cr |
Pharmaceuticals & Biotechnology | 10.67% | 9.88% | -0.79% |
| 2 | IPCA Laboratories Limited ₹6.15 Cr |
Pharmaceuticals & Biotechnology | 4.23% | 3.76% | -0.47% |
| 3 | Biocon Limited ₹7.43 Cr |
Pharmaceuticals & Biotechnology | 4.90% | 4.54% | -0.36% |
| 4 | Alkem Laboratories Limited ₹9.15 Cr |
Pharmaceuticals & Biotechnology | 5.90% | 5.58% | -0.32% |
| 5 | JB Chemicals & Pharmaceuticals Limited ₹4.84 Cr |
Pharmaceuticals & Biotechnology | 3.21% | 2.96% | -0.25% |
| 6 | Abbott India Limited ₹3.83 Cr |
Pharmaceuticals & Biotechnology | 2.56% | 2.34% | -0.22% |
| 7 | Ajanta Pharma Limited ₹3.44 Cr |
Pharmaceuticals & Biotechnology | 2.25% | 2.10% | -0.15% |
| 8 | Gland Pharma Limited ₹4.03 Cr |
Pharmaceuticals & Biotechnology | 2.57% | 2.46% | -0.11% |
| 9 | Pfizer Limited ₹2.07 Cr |
Pharmaceuticals & Biotechnology | 1.36% | 1.26% | -0.10% |
| 10 | Aster DM Healthcare Limited ₹5.14 Cr |
Healthcare Services | 3.23% | 3.14% | -0.09% |
30 stocks — Apr 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹16.18 Cr |
Pharmaceuticals & Biotechnology |
9.88%
|
|
| 2 |
₹13.92 Cr |
Healthcare Services |
8.50%
|
|
| 3 |
₹12.40 Cr |
Pharmaceuticals & Biotechnology |
7.57%
|
|
| 4 |
₹11.24 Cr |
Pharmaceuticals & Biotechnology |
6.86%
|
|
| 5 |
₹10.49 Cr |
Pharmaceuticals & Biotechnology |
6.40%
|
|
| 6 |
₹9.15 Cr |
Pharmaceuticals & Biotechnology |
5.58%
|
|
| 7 |
₹7.43 Cr |
Pharmaceuticals & Biotechnology |
4.54%
|
|
| 8 |
₹7.36 Cr |
Pharmaceuticals & Biotechnology |
4.49%
|
|
| 9 |
₹6.15 Cr |
Pharmaceuticals & Biotechnology |
3.76%
|
|
| 10 |
₹5.14 Cr |
Healthcare Services |
3.14%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.